NMRA
Neumora TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
Current thesis
The bullish case is now almost entirely balance-sheet-plus-optional-pipeline: management still points to runway into the third quarter of 2027, and NMRA-511, NMRA-898, and NMRA-215 together give the company multiple shots at rebuilding value if one of the remaining programs shows credible data [#SEC-8K-2026-05-07] [#8-K-2026-06-15].
Posture
Mixed
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
A June 10, 2026 loan amendment changed the interest-only period and introduced a minimum-liquidity covenant effective July 1, 2026, adding financing and covenant-monitoring risk if market cap or operational milestones weaken [#8-K-2026-06-15].
Momentum
98
Value
41
Sentiment
23
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.10 · Bull $2.40 · Bear $0.45
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-06-18 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $6.14
Why
Momentum98 · Δ7d -
Value41 · Δ7d -0.1
Sentiment23 · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Momentum · See technicals
Momentum
98
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
0.0
Sentiment
23
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 98.3 / Value 41.1 / Sentiment 22.9
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$298.31M
Beta
-
Shares Out
185.28M
P/E (TTM) · Derived
-1.1
P/S (TTM)
-
P/FCF (TTM) · Derived
-1.39
Rev YoY
-
EPS YoY
-29.4%
Gross Margin
-
Op Margin
-
Net Debt
-$127.52M
Current Ratio
5.09
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology